Table 1.
Clinical characteristics and demographics.
n | 64 |
---|---|
Median Age (range) | 59 (24-96) |
Male (%) | 34 (53%) |
Race (%) | |
White or Caucasian | 48 (75%) |
Black or African American | 13 (20%) |
Hispanic | 1 (2%) |
Not recorded | 2 (3%) |
Weight (Kg) | 99.8 (41-190) |
BMI median (range) | 35.6 (17.2-66.1) |
Comorbidity | |
Obesity, patient number (%) | 42 (66%) |
Hypertension, patient number (%) | 39 (61%) |
Diabetes Mellitus, patient number (%) | 26 (41%) |
Coronary artery disease/arrhymia/CHF, patient number (%) | 20 (31%) |
Underlying lung disease, patient number (%) | 21 (33%) |
Chronic kidney disease, patient number (%) | 7 (11%) |
Hyperlipidemia, patient number (%) | 14 (22%) |
Hospital Day Neutrophils Obtained
mean/median (range) |
8.5/6.5 (1-36) |
Laboratory Values | |
WBC/Neutrophil (4.1-10.8 x103/μL) mean/median | 13.6/11.7 |
NLR mean/median | 20.5/12.5 |
d-dimer (0.19-0.74 μg/ml FEU) | 423, range 0.37-15,107 (n=40) |
Ferritin (7-350 ng/ml) | 711, range 71-7500 (n=34) |
C-reactive protein (<3.0 mg/L) | 177, range 2.6-380 (n=30) |
Hospital Course | |
APACHE | 21, range 6-38 |
ICU, patient number (%) | 59 (92%) |
Ventilator, patient number (%) | 57 (89%) |
ECMO, patient number (%) | 6 (9%) |
Dialysis, patient number (%) | 16 (25%) |
Died, patient number (%) | 32 (50%) |
Discharge Home, patient number (%) | 9 (14%) |
Discharge to LTC, patient number (%) | 22 (34%) |
Treatment | |
Remdesivir, patient number (%) | 48 (75%) |
Corticosteroids, patient number (%) | 59 (92%) |
Monoclonal antibody or Convalescent Plasma, patient number (%) | 29 (45%) |